Patient characteristics
Characteristics . | MEL100 . | MP . |
|---|---|---|
| No. | 95 | 99 |
| Age | ||
| Median age, y | 65 | 63 |
| Range, y | 51-70 | 52-70 |
| 65 or older, % | 46.3 | 36.4 |
| Gender | ||
| Male, no. (%) | 51 (54) | 54 (55) |
| Female, no. (%) | 44 (46) | 45 (45) |
| Stage | ||
| IIA, no. (%) | 34 (36) | 32 (32) |
| IIB, no. (%) | 3 (3) | 5 (5) |
| IIIA, no. (%) | 53 (56) | 58 (58) |
| IIIB, no. (%) | 5 (5) | 4 (4) |
| Median β2-microglobulin, nM/L (mg/L) | 246.5 (2.9) | 246.5 (2.9) |
| β2-microglobulin | ||
| Less than 255 nM/L, no. (%) | 37 (39) | 40 (40) |
| At least 255 nM/L, no. (%) | 46 (48) | 37 (37) |
| Data missing, no. (%) | 12 (13) | 22 (22) |
| M-protein class | ||
| IgG, no. (%) | 64 (67) | 59 (60) |
| IgA, no. (%) | 22 (23) | 27 (27) |
| Bence Jones protein, no. (%) | 8 (9) | 11 (11) |
| Others, no. (%) | 1 (1) | 2 (2) |
Characteristics . | MEL100 . | MP . |
|---|---|---|
| No. | 95 | 99 |
| Age | ||
| Median age, y | 65 | 63 |
| Range, y | 51-70 | 52-70 |
| 65 or older, % | 46.3 | 36.4 |
| Gender | ||
| Male, no. (%) | 51 (54) | 54 (55) |
| Female, no. (%) | 44 (46) | 45 (45) |
| Stage | ||
| IIA, no. (%) | 34 (36) | 32 (32) |
| IIB, no. (%) | 3 (3) | 5 (5) |
| IIIA, no. (%) | 53 (56) | 58 (58) |
| IIIB, no. (%) | 5 (5) | 4 (4) |
| Median β2-microglobulin, nM/L (mg/L) | 246.5 (2.9) | 246.5 (2.9) |
| β2-microglobulin | ||
| Less than 255 nM/L, no. (%) | 37 (39) | 40 (40) |
| At least 255 nM/L, no. (%) | 46 (48) | 37 (37) |
| Data missing, no. (%) | 12 (13) | 22 (22) |
| M-protein class | ||
| IgG, no. (%) | 64 (67) | 59 (60) |
| IgA, no. (%) | 22 (23) | 27 (27) |
| Bence Jones protein, no. (%) | 8 (9) | 11 (11) |
| Others, no. (%) | 1 (1) | 2 (2) |